Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corcept Therapeutics (CORT) Current Leases (2019 - 2025)

Corcept Therapeutics (CORT) has disclosed Current Leases for 7 consecutive years, with $1.1 million as the latest value for Q4 2025.

  • Quarterly Current Leases rose 30.76% to $1.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.1 million through Dec 2025, up 30.76% year-over-year, with the annual reading at $1.1 million for FY2025, 30.76% up from the prior year.
  • Current Leases hit $1.1 million in Q4 2025 for Corcept Therapeutics, up from $1.0 million in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $2.3 million in Q1 2022 to a low of $44000.0 in Q2 2024.
  • Historically, Current Leases has averaged $967000.0 across 5 years, with a median of $1.0 million in 2025.
  • Biggest five-year swings in Current Leases: crashed 86.88% in 2023 and later surged 2211.36% in 2025.
  • Year by year, Current Leases stood at $526000.0 in 2021, then skyrocketed by 117.3% to $1.1 million in 2022, then crashed by 86.79% to $151000.0 in 2023, then soared by 449.01% to $829000.0 in 2024, then soared by 30.76% to $1.1 million in 2025.
  • Business Quant data shows Current Leases for CORT at $1.1 million in Q4 2025, $1.0 million in Q3 2025, and $1.0 million in Q2 2025.